Terr Ascend Corp. TRSSF
We take great care to ensure that the data presented and summarized in this overview for TerrAscend Corp. is accurate and up-to-date, based on a comprehensive analysis of 13F filing forms for institutional ownership and form 4 filings for insider transactions. Please note that this data may differ from other sources and should not be relied upon as the sole basis for investment decisions.
Top Institutions Holding TRSSF
View allLatest Institutional Activity in TRSSF
Top Purchases
Top Sells
About TRSSF
TerrAscend Corp. cultivates, processes, and sells medical and adult use cannabis in Canada and the United States. It produces and distributes hemp-derived wellness products to retail locations; and manufactures cannabis infused artisan edibles. The company also operates three retail dispensaries under the Apothecarium brand name in California and Pennsylvania. In addition, it owns various synergistic under Gage Cannabis, Ilera Healthcare, Kind Tree, Prism, State Flower, Valhalla Confections, and Arise Bioscience Inc. brands. As of July 26, 2022, the company operated 27 dispensaries, including 3 Cookies dispensaries in Michigan and 1 in Toronto. TerrAscend Corp. was incorporated in 2017 and is headquartered in Mississauga, Canada.
Insider Transactions at TRSSF
Insider Transaction List
View all| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 17
2024
|
Edward J Schutter |
BUY
Grant, award, or other acquisition
|
Direct |
155,059
+8.78%
|
-
|
|
Jun 17
2024
|
Ira Duarte |
BUY
Grant, award, or other acquisition
|
Direct |
163,334
+35.56%
|
-
|
|
Jun 17
2024
|
Kara Dio Guardi |
BUY
Grant, award, or other acquisition
|
Direct |
153,556
+31.17%
|
-
|
|
Jun 17
2024
|
Craig A Collard |
BUY
Grant, award, or other acquisition
|
Direct |
163,334
+18.56%
|
-
|
|
Jun 17
2024
|
Jw Asset Management, LLC Executive Chairman |
BUY
Grant, award, or other acquisition
|
Direct |
362,161
+0.4%
|
-
|
|
Apr 08
2024
|
Keith Stauffer CFO |
SELL
Payment of exercise price or tax liability
|
Direct |
41,357
-5.71%
|
$82,714
$2.01 P/Share
|
|
Apr 08
2024
|
Keith Stauffer CFO |
BUY
Grant, award, or other acquisition
|
Direct |
217,588
+23.09%
|
-
|
|
Apr 08
2024
|
Ziad Ghanem PRESIDENT AND CEO |
BUY
Grant, award, or other acquisition
|
Direct |
251,256
+35.67%
|
-
|
|
Apr 08
2024
|
Lynn K Gefen CHIEF LEGAL OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
5,471
-3.56%
|
$10,942
$2.01 P/Share
|
|
Apr 08
2024
|
Lynn K Gefen CHIEF LEGAL OFFICER |
BUY
Grant, award, or other acquisition
|
Direct |
100,503
+26.36%
|
-
|
|
Mar 25
2024
|
Keith Stauffer CFO |
SELL
Payment of exercise price or tax liability
|
Direct |
1,938
-0.38%
|
$1,938
$1.72 P/Share
|
|
Mar 21
2024
|
Keith Stauffer CFO |
SELL
Payment of exercise price or tax liability
|
Direct |
11,198
-2.15%
|
$11,198
$1.83 P/Share
|
|
Dec 22
2023
|
Jw Asset Management, LLC Executive Chairman |
BUY
Open market or private purchase
|
Indirect |
12,000
+0.01%
|
$12,000
$1.46 P/Share
|
|
Dec 18
2023
|
Jw Asset Management, LLC Executive Chairman |
BUY
Open market or private purchase
|
Indirect |
15,000
+0.02%
|
$15,000
$1.39 P/Share
|
|
Dec 11
2023
|
Jw Asset Management, LLC Executive Chairman |
BUY
Open market or private purchase
|
Indirect |
10,000
+0.01%
|
$10,000
$1.53 P/Share
|
|
Dec 06
2023
|
Jw Asset Management, LLC Executive Chairman |
BUY
Open market or private purchase
|
Indirect |
10,000
+0.01%
|
$10,000
$1.59 P/Share
|
|
Dec 04
2023
|
Jw Asset Management, LLC Executive Chairman |
BUY
Open market or private purchase
|
Indirect |
15,000
+0.02%
|
$15,000
$1.58 P/Share
|
|
Nov 20
2023
|
Jw Asset Management, LLC Executive Chairman |
BUY
Open market or private purchase
|
Indirect |
12,000
+0.01%
|
$12,000
$1.49 P/Share
|
|
Nov 17
2023
|
Jw Asset Management, LLC Executive Chairman |
BUY
Open market or private purchase
|
Indirect |
18,200
+0.02%
|
$18,200
$1.51 P/Share
|
|
Nov 15
2023
|
Jw Asset Management, LLC Executive Chairman |
BUY
Open market or private purchase
|
Indirect |
15,000
+0.02%
|
$15,000
$1.56 P/Share
|
Last 12 Months Summary
| Grant, award, or other acquisition | 1.74M shares |
|---|---|
| Open market or private purchase | 675K shares |
| Payment of exercise price or tax liability | 60K shares |
|---|